Search

Author/Creator Moser, Stephan

1. SaO039RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (CONESTAT ALFA) IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN HIGH-RISK PATIENTS (PROTECT): A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND SINGLE-CENTER TRIAL. (13th June 2019)

Authors:
Panagiotou, Anneza; Moser, Stephan; Breidthardt, Tobias; Heijnen, Ingmar; Fahrni, Gregor; Kaiser, Christoph; Bonati, Leo; Trendelenburg, Marten; Jeger, Raban; Osthoff, Michael
Journal:
Nephrology dialysis transplantation
Issue:
Volume 34(2019)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs. (8th April 2021)

Authors:
Moser, Stephan; Rehm, Sophia; Guertler, Nicolas; Hinic, Vladimira; Dräger, Sarah; Bassetti, Stefano; Rentsch, Katharina M; Sendi, Parham; Osthoff, Michael
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 76:Number 7(2021)
Page Start:
1845
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Interferon/Ribavirin‐Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C. (May 2016)

Authors:
Stern, Rafael; Hametner, Stephanie; Ramona, Al‐Zoairy; Moser, Stephan; Karpi, Asia; Laferl, Hermann; Stauber, Rudolf E; Zoller, Heinz M; Maieron, Andreas; Vogel, Wolfgang; Graziadei, Ivo; Gschwantler, Michael; Kozbial, Karin; Freissmuth, Clarissa; Hofer, Harald; Ferenci, Peter
Journal:
American journal of gastroenterology
Issue:
Volume 111:Number 5(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Direct Observed Therapy of Chronic Hepatitis C With Interferon‐Free All‐Oral Regimens at a Low‐Threshold Drug Treatment Facility—a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy. (June 2016)

Authors:
Schìtz, Angelika; Moser, Stephan; Marchart, Katharina; Haltmayer, Hans; Gschwantler, Michael
Journal:
American journal of gastroenterology
Issue:
Volume 111:Number 6(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment. (1st December 2017)

Authors:
Kozbial, Karin; Moser, Stephan; Al‐Zoairy, Ramona; Schwarzer, Remy; Datz, Christian; Stauber, Rudolf; Laferl, Hermann; Strasser, Michael; Beinhardt, Sandra; Stättermayer, Albert F.; Gschwantler, Michael; Zoller, Heinz; Maieron, Andreas; Graziadei, Ivo; Trauner, Michael; Steindl‐Munda, Petra; Hofe...
Journal:
Liver international
Issue:
Volume 38:Number 6(2018)
Page Start:
1028
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. Issue 3 (March 2018)

Authors:
Moser, Stephan; Kozbial, Karin; Laferl, Hermann; Schütz, Angelika; Reiberger, Thomas; Schwabl, Philipp; Gutic, Enisa; Schwanke, Cornelia; Schubert, Raphael; Luhn, Julian; Lang, Tobias; Schleicher, Michael; Steindl-Munda, Petra; Haltmayer, Hans; Ferenci, Peter; Gschwantler, Michael
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 30:Issue 3(2018:Mar.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗